Mechanosignaling promotes macrophage apoptosis resistance in pulmonary fibrosis via metabolic reprogramming
Year: 2026
Type: preprint
Abstract: ABSTRACT The mechanisms underlying disease progression in idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases remain unclear. Increased extracellular matrix stiffness is a hallmark of fibrotic lung diseases, while monocyte-derived macrophages promote fibrosis progression. However, there is limited understanding if mechanical properties of the fibrotic microenvironment influence macrophage phenotypes and fibrogenesis. Profibrotic macrophages are resistant to apoptosis, which is modulated by enhanced mitochondrial bioenergetics. The objective of this study is to determine how lung tissue stiffness impacts macrophage phenotypes and fibrotic progression. We demonstrate that mechanoactivated macrophages exhibit apoptosis-resistance, increased expression of the antiapoptotic protein Bcl-xL, and elevated mitochondrial oxidative phosphorylation. Critically, the metabolic reprogramming observed in mechanoactivated macrophages is dependent on increased glutaminolysis. Inhibition of glutaminolysis attenuated apoptosis resistance in mechanoactivated macrophages. Moreover, inhibition of Bcl-xL in vivo protected mice against experimental pulmonary fibrosis. Lastly, mechanoactivated macrophages produce more profibrotic cytokines and promote extracellular matrix production in precision-cut lung slices. We describe a mechanism by which extracellular matrix stiffness mediates macrophage apoptosis resistance and metabolic reprogramming. Our results identify mechanoactivated apoptosis-resistant macrophages as pro-fibrotic mediators, suggesting a novel therapeutic target in IPF and related fibrotic disorders. GRAPHIC ABSTRACT
Authors: Chao He, Cristian Coarfa, Neftali Garcia, Olubunmi C. Lebimoyo, Haiwei Gu, Elisa Ruiz-Echartea, Xiaoli Ji, Alan Waich, Juan D. Zuluaga, Lindsay J. Celada, Scott A. Ochsner, Neil J. McKenna, Jennifer L. Larson-Casey, Sandeep K. Agarwal, Farrah Kheradmand, Yong Zhou, A. Brent Carter, Ivan O. Rosas
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: idiopathic pulmonary fibrosis, mechanosensitive signaling, extracellular matrix stiffness, metabolic reprogramming, glutaminolysis, Bcl-xL, mitochondrial oxidative phosphorylation, monocyte-derived macrophages, profibrotic cytokines, extracellular matrix synthesis, interstitial lung disease
Open Access status: green
Funders: Cancer Prevention and Research Institute of Texas, National Institutes of Health, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: High Memory High-Performance Computer Cluster for Biomedical Research, Proteomics and Metabolomics Core Facility, ACQUISITION OF THE YOKOGAWA CV8000 HIGH THROUGHPUT SPINNING DISK MICROSCOPE AND ROBOTICS, HIGH THROUGHPUT NGS SEQUENCER AT THE BCM GENOMIC AND RNA PROFILING CORE, Noradrenergic mechanisms in breathing and respiratory pathophysiologies, Mechano-niche in Lung Repair after Injury, G7837447426, G8263402814, G8663069304, Mechanosignaling regulates macrophage immunometabolism, The BCM Knockout Mouse Production and Phenotyping Project (BCM KOMP2), The Desmosome-Keratin Intermediate Filament Network in Lung Epithelial Injury, Repair and Regeneration, Metabolic Impacts of Type II Interferon Signals in Obesity, Gulf Coast Center for Precision Environmental Health, Regulation of disease progression by ER stress, Texas Medical Center Digestive Diseases Center, Baylor College of Medicine Cancer Center - Cancer Center Support Grant, UNDERSTANDING CADHERIN-11 IN THE DEVELOPMENT AND TREATMENT OF LUNG FIBROSIS, Macrophage-fibroblast interaction is required for asbestos-induced toxicity, POLYCYCLIC AROMATIC HYDROCARBONS: ULTRASENSITIVE DETECTION,EARLY LIFE EXPOSURES-CLINICAL OUTCOMES (PRETERM BIRTHS, CHRONICLUNG DISEASE, AND NEUROCOGNITIVE DEFICITS), PREVENTION ANDREMEDIATION, Consortium for Translational and Precision Health
OpenAlex ID: W7204124351
